Bottom line
SHSAX vs IYH: the short answer
SHSAX (Blackrock Health Sciences Opportunities Portfolio) and IYH (iShares U.S. Healthcare ETF) are both mutual funds.
IYH is cheaper at 0.37% vs 1.11% — a difference of $74 a year per $10,000 invested.
Over five years, IYH returned +7.0% a year vs +4.5% for SHSAX.
SHSAX has a front-end sales load of up to 5.25%; the other does not.
Updated Nov 19, 2026
SHSAX vs IYH side by side
| SHSAX | IYH | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | BlackRock | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.11% | 0.37% |
| Annual cost per $10k | $111 | $37 |
| 10-yr cost on $10k (prospectus) | $1,806 | $468 |
| Max front load | 5.25% | None |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +9.9% | +13.1% |
| 5-yr return (annualized) | +4.5% | +7.0% |
| 10-yr return (annualized) | +9.0% | +9.4% |
| Best quarter | +17.5% | +15.3% |
| Worst quarter | −11.5% | −12.7% |
| Net assets (fund) | $5.9B | $3.6B |
| Number of holdings | 155 | 103 |
| Portfolio turnover | 49% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SHSAX | IYH | Difference |
|---|---|---|---|
| 2025 | +16.0% | +13.1% | +2.8% |
| 2024 | +3.9% | +3.1% | +0.8% |
| 2023 | +3.6% | +2.1% | +1.5% |
| 2022 | −5.9% | −4.4% | −1.5% |
| 2021 | +11.8% | +23.4% | −11.6% |
| 2020 | +19.5% | +15.5% | +4.0% |
| 2019 | +25.3% | +20.8% | +4.5% |
| 2018 | +8.0% | +5.9% | +2.1% |
| 2017 | +24.8% | +22.3% | +2.5% |
| 2016 | −6.1% | −2.8% | −3.2% |
Source: Fund prospectus bar charts
Holdings overlap
19 of SHSAX's top 25 holdings also appear in IYH's top 25.
| Holding | SHSAX | IYH |
|---|---|---|
| Eli Lilly & Company | 12.29% | 15.11% |
| Johnson & Johnson | 8.77% | 10.17% |
| Unitedhealth Group Inc | 6.10% | 6.16% |
| Merck & Company Inc | 4.94% | 5.31% |
| Gilead Sciences Inc | 4.19% | 2.66% |
| Abbvie Inc | 3.94% | 7.32% |
| Amgen Inc | 3.37% | 3.42% |
| Thermo Fisher Scientific Inc | 3.02% | 3.52% |
| Vertex Pharmaceuticals Inc | 2.74% | 2.00% |
| Pfizer Inc | 2.61% | 2.35% |
| Edwards Lifesciences Corp | 2.51% | 0.81% |
| Danaher Corp | 2.00% | 2.03% |
| Abbott Laboratories | 1.97% | 3.02% |
| Intuitive Surgical Inc | 1.95% | 2.05% |
| Boston Scientific Corp | 1.59% | 1.14% |
Source: SEC Form N-PORT
SHSAX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
IYH top 10
- Eli Lilly And Company — 15.11%
- Johnson & Johnson — 10.17%
- Abbvie Inc. — 7.32%
- Unitedhealth Group Incorporated — 6.16%
- Merck & Co., Inc. — 5.31%
- Thermo Fisher Scientific Incorporated — 3.52%
- Amgen Inc. — 3.42%
- Abbott Laboratories — 3.02%
- Gilead Sciences, Inc. — 2.66%
- Pfizer Inc. — 2.35%
FAQ
What is the difference between SHSAX and IYH?
Which is cheaper, SHSAX or IYH?
Should I own both SHSAX and IYH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.